KIAA0415 inhibitors are a class of chemical compounds that target the KIAA0415 protein, which is also known by its alternative name, CCDC22. KIAA0415 is a coiled-coil domain-containing protein that is involved in various cellular processes, including protein trafficking and the regulation of nuclear factor-kappa B (NF-κB) signaling. This protein plays a critical role in cellular homeostasis by modulating endosomal sorting and recycling pathways, and its proper function is necessary for maintaining normal cellular activity. Inhibitors of KIAA0415 typically function by interfering with its structural or functional domains, ultimately altering the downstream signaling pathways and processes in which the protein is involved. These inhibitors may exert their effects by binding to specific regions of the KIAA0415 protein, leading to a reduction in its interaction with other molecular partners involved in intracellular transport and signal transduction.
The development and study of KIAA0415 inhibitors provide insights into the broader biological functions of this protein, especially in the context of cellular signaling networks. By inhibiting KIAA0415, researchers can observe changes in processes such as endocytosis, receptor recycling, and signal amplification pathways like NF-κB. This can also help identify new molecular mechanisms of action related to protein trafficking and degradation, as well as their implications for broader regulatory networks in cellular biology. KIAA0415 inhibitors are valuable tools for elucidating the roles of coiled-coil domain-containing proteins and understanding their contributions to maintaining cellular integrity. Further exploration of these inhibitors allows for a deeper understanding of the pathways affected by KIAA0415 and its broader implications in cellular systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may activate specific transcription factors that repress the promoter activity of the KIAA0415 gene, leading to a decrease in its mRNA synthesis. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into the DNA of the KIAA0415 gene, this compound could induce hypomethylation, potentially resulting in the silencing of gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might bind to and inhibit mTOR complex 1 (mTORC1), which could lead to reduced translation of KIAA0415 mRNA into protein due to decreased cap-dependent initiation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This HDAC inhibitor may increase acetylation of histones near the KIAA0415 gene, which could reposition nucleosomes, obstructing the access of transcription machinery and thus reducing gene expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate might deplete the pool of tetrahydrofolate, leading to a shortfall in purine nucleotides, which could curtail the transcription of the KIAA0415 gene. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
By intercalating into DNA, Actinomycin D could obstruct RNA polymerase movement along the KIAA0415 gene, which would lead to a cessation of transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 might competitively inhibit binding of BET bromodomain proteins to acetylated lysines, potentially leading to a repressed chromatin state at the KIAA0415 locus and a consequent decrease in its gene expression. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
This compound could disrupt the splicing machinery, leading to defective or reduced splicing of pre-mRNA for KIAA0415, which would decrease the level of mature mRNA available for translation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could inhibit lysosomal activity, which might induce a stress response that includes the repression of certain genes, possibly including the KIAA0415 gene, thus reducing its overall expression. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Stattic may selectively inhibit STAT3, which is potentially involved in the transcriptional activation of the KIAA0415 gene; inhibition of STAT3 could therefore result in reduced expression of this protein. | ||||||